CR1 genotype and haplotype involvement in coronary artery disease: The pivotal role of hypertension and dyslipidemia

International Journal of Molecular Medicine

Volumn 24, Issue 2, 2009, Pages 181-187

  Boiocchi, Chiara ^a   Zorzetto, Michele ^a   Sbarsi, Ilaria ^a   Pirotta, Alessandro ^a   Schirinzi, Sandra ^a   Falcone, Colomba ^a   Cuccia, Mariaclara ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Atherosclerosis; Coronary artery disease; CR1 genetics; Hypertension; Inflammation

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; AGED; GENETICS; GENOTYPE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, COMPLEMENT 3B;

EID: 70349327660     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000221     Document Type: Article

References (45)

1. Cambien F, Poirier O, Mallet C and Tiret L: Coronary heart disease and genetics in epidemiologist's view. Mol Med Today 3: 197-203, 1997.
2. Lusis AJ: Atherosclerosis. Nature 407: 233-241, 2000.
3. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 138: S419-S420, 1999.
4. Koenig W: Inflammation and coronary heart disease: an overview. Cardiol Rev 9: 31-35, 2001.
5. Haskard DO, Boyle JJ and Mason JC: The role of complement in atherosclerosis. Curr Opin Lipidol 19: 478-482, 2008.
6. Oksjoki R, Kovanen PT, Meri S and Pentikainen MO: Function and regulation of the complement system in cardiovascular diseases. Front Biosci 12: 4696-4708, 2007.
7. Leitinger N: The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Subcell Biochem 49: 325-350, 2008.
8. Vaisar T, Pennathur S, Green PS, et al: Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 117: 746-756, 2007.
9. Bhakdi S, Lackner KJ, Han SR, Torzewski M and Husmann M: Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb Haemost 91: 639-645, 2004.
10. Niculescu F and Rus H: Complement activation and atherosclerosis. Mol Immunol 36: 949-955, 1999.
11. Niculescu F, Badea T and Rus H: Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 142: 47-56, 1999.
12. Fearon DT and Wong WW: Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol 1: 243-271, 1983.
13. Walport MJ: Complement. First of two parts. N Engl J Med 344: 1058-1066, 2001.
14. Oudin S, Libyh MT, Goossens D, et al: A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes. J Immunol 164: 1505-1513, 2000.
15. Ripoche J and Sim RB: Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor. Biochem J 235: 815-821, 1986.
16. Herrera AH, Xiang L, Martin SG, Lewis J and Wilson JG: Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 87: 176-183, 1998.
17. Xiang L, Rundles JR, Hamilton DR and Wilson JG: Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 163: 4939-4945, 1999.
18. Wilson AG, Symons JA, McDowell TL, McDevitt HO and Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195-3199, 1997.
19. Moulds JM, Brai M, Cohen J, et al: Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 15: 291-294, 1998.
20. Berliner J, Leitinger N, Watson A, Huber J, Fogelman A and Navab M: Oxidized lipids in atherogenesis: formation, destruction and action. Thromb Haemost 78: 195-199, 1997.
21. Libby P: Inflammation in atherosclerosis. Nature 420: 868-872, 2002.
22. Libby P and Galis ZS: Cytokines regulate genes involved in atherogenesis. Ann NY Acad Sci 748: 168-170, 1995.
23. Falcone C, Geroldi D, Buzzi MP, et al: The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch Med Res 39: 320-325, 2008.
24. Nora JJ, Lortscher RH, Spangler RD, Nora AH and Kimberling WJ: Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 61: 503-508, 1980.
25. Libby P: Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65: S140-S146, 2007.
26. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U and Hansson GK: Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145: 33-43, 1999.
27. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
28. Mannik M, Arend MP, Hall AP and Gilliland BC: Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med 133: 713-739, 1971.
29. Qiao JH, Castellani LW, Fishbein MC and Lusis AJ: Immunecomplex- mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb 13: 932-943, 1993.
30. Beaumont JL: Auto-immune hyperlipidemia. An atherogenic metabolic disease of immune origin. Rev Eur Etud Clin Biol 15: 1037-1041, 1970.
31. Poston RN and Davies DF: Immunity and inflammation in the pathogenesis of atherosclerosis. A review. Atherosclerosis 19: 353-367, 1974.
32. Spiera H and Rothenberg RR: Myocardial infarction in four young patients with SLE. J Rheumatol 10: 464-466, 1983.
33. Nieminen MS, Mattila K and Valtonen V: Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 14K: 12-16, 1993.
34. Grant PJ: The genetics of atherothrombotic disorders: a clinician's view. J Thromb Haemost 1: 1381-1390, 2003.
35. Goldbourt U and Neufeld HN: Genetics aspects of arteriosclerosis. Arteriosclerosis 6: 357-377, 1988.
36. Andreotti F, Porto I, Crea F and Maseri A: Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 87: 107-112, 2002.
37. Torzewski M, Klouche M, Hock J, et al: Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol 18: 369-378, 1998.
38. Laine P, Pentikainen MO, Wurzner R, Penttilä A, Paavonen T, Meri S and Kovanen PT: Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am J Cardiol 90: 404-408, 2002.
39. Hammerschmidt DE, Greenberg CS, Yamada O, Craddock PR and Jacob HS: Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states. J Lab Clin Med 98: 68-77, 1981.
40. Yasuda M, Takeuchi K, Hiruma M, et al: The complement system in ischemic heart disease. Circulation 81: 156-163, 1990.
41. Rother K, Till GO and Haensch GM: The Complement System. 2nd edition. Springer, Berlin, 1998.
42. Saito E, Fujioka T, Kanno H, et al: Complement receptors in atherosclerotic lesions. Artery 19: 47-62, 1992.
43. Zorzetto M, Ferrarotti I, Trisolini R, et al: Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168: 330-334, 2003.
44. Vongpatanasin W: Management of hypertension in patients with coronary artery disease. Curr Hypertens Rep 10: 349-354, 2008.
45. Taddei S, Virdis A, Ghiadoni L, Salvetti G and Salvetti A: Endothelial dysfunction in hypertension. J Nephrol 13: 205-210, 2000.